PMID: 16634367Apr 26, 2006Paper

Primary systemic vasculitis: treatment of difficult cases

Lupus
R FosterD D'Cruz

Abstract

The primary systemic necrotizing vasculitides are a severe group of diseases, which untreated have a high mortality. The majority respond to treatment with high dose steroids and cyclophosphamide, however a significant proportion of those treated suffer morbidity due to the side effects of these agents, and a number of patients are refractory to treatment. We review and discuss alternative and emerging treatment options for patients who fail or cannot tolerate conventional therapy. An interesting subgroup of patients with systemic vasculitis and antiphospholipid antibodies provides an additional diagnostic and therapeutic challenge. We review what is known about this subgroup, and suggest screening for antiphospholipid antibodies in all patients with systemic vasculitis.

References

Mar 15, 1992·Annals of Internal Medicine·G S HoffmanA S Fauci
Oct 1, 1987·British Journal of Rheumatology·E N Harris
Oct 15, 1983·British Medical Journal·G R Hughes
Oct 1, 1984·Annals of the Rheumatic Diseases·R G HullG R Hughes
Dec 1, 1994·Lupus·R de la Fuente Fernandez, J Graña Gil
Jan 1, 1995·American Journal of Nephrology·S CohneyM R Stewart
Dec 24, 1997·British Journal of Rheumatology·B DasguptaA Tanqueray
Dec 16, 1998·British Journal of Rheumatology·B SerioloS Accardo
Jun 30, 2000·QJM : Monthly Journal of the Association of Physicians·D R JayneC M Lockwood
Jul 11, 2000·Rheumatology·D Jayne
Sep 27, 2001·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·K de GrootUNKNOWN EUVAS (European vasculitis study group)
Apr 16, 2002·Arthritis and Rheumatism·Ricard CerveraUNKNOWN Euro-Phospholipid Project Group
Jun 29, 2002·Journal of the American Society of Nephrology : JASN·Lavanya KameshCaroline O S Savage
Jul 4, 2003·The New England Journal of Medicine·David JayneUNKNOWN European Vasculitis Study Group
Feb 24, 2004·Journal of the American Society of Nephrology : JASN·Anthony BoothDavid Jayne
Oct 28, 2004·Thrombosis Research·P L MeroniF Tedesco
Jan 28, 2005·The New England Journal of Medicine·UNKNOWN Wegener's Granulomatosis Etanercept Trial (WGET) Research Group
Sep 2, 2005·Scandinavian Journal of Rheumatology·R OmdalG Kristoffersen
Nov 15, 2005·Annals of the Rheumatic Diseases·S N PaulD P D'Cruz
Dec 14, 2005·Annals of the Rheumatic Diseases·J D ReesD P D'Cruz

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antiphospholipid Syndrome

Antiphospholipid syndrome or antiphospholipid antibody syndrome (APS or APLS), is an autoimmune, hypercoagulable state caused by the presence of antibodies directed against phospholipids.